Zhengrong Cui

Technologies

• A pharmaceutical compound for targeted cancer therapy using nucleobase analog derivatives with omega-3 fatty acids
• Nanoparticle technology for sustained release of therapeutic agents
• Layered simulation software for optimizing freeze-drying of porous particle beds
• Thin film freezing technology for stable dry formulations of mRNA therapeutics
• Dry powder cell formulations for long-term viability and therapeutic applications
• Spray-dried RNA-lipid nanoparticle dry powder technology for stable and inhalable delivery of therapeutics
• Microneedle array coating technology for enhanced stability and targeted delivery of mRNA and biologics
• Thin-film freeze-dried antibiotic powders for fixed-dose pulmonary delivery